E.g., 03/04/2021
E.g., 03/04/2021
Title Category Credit Event Datesort descending Price
Drug Development in NMIBC from Scientific, Regulatory, Clinician, and Patient Perspectives (2021)
    • 10.75 AMA PRA Category 1 Credit™
    • 10.75 Non-Physician Participation
03/04/2021 $200.00 Registration is closed for this event. Johns Hopkins Greenberg Bladder Cancer Institute and American Urological Association Translational Research CollaborationThe fourth annual bladder cancer translational research meeting, co-sponsored by the American Urological Association and the Johns Hopkins Greenberg Bladder Cancer Institute, will be a three-day, virtual workshop focused on the science and treatment of non-muscle-invasive bladder cancer.
Live Webinar 1: PARP Inhibitors: Assessing the Rapidly Evolving Treatment Landscape (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
03/24/2021 $0.00 Complimentary CME Webinar!Wednesday, March 24, 2021 | 7:00 - 8:00 p.m. ESTPARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors.
Metastatic Hormone Sensitive Prostate Cancer: Expert Guidance for Urologists (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
03/25/2021 $0.00 Complimentary CME Webinar!Thursday, March 25, 2021 | 7:00 - 8:00 p.m. ESTIn just the last decade, the FDA has approved several new therapies for the treatment of prostate cancer. It is critical for urologists to understand the sequencing of agents for the treatment of mHSPC because of the overlapping toxicities and the increasing role for treating mHSPC patients.
Oral Board Review Course (2021) 04/09/2021 $1,865.00 Web Update: Notice Regarding the Status of the Oral Board Review Course (January 26, 2021)On January 18, 2021, the American Board of Urology (ABU) announced that the Certifying (Part 2) Exam will be virtual. The AUA Oral Board Review Course will also take place as a live virtual course. The AUA Oral Board Review Course will continue to take place over the scheduled dates of April 9-10, 2021.  We are working on the virtual program details and will provide updates to this website on or before Monday, February 1, 2021. 
Live Webinar 2: PARP Inhibitors: Assessing the Clinical Trial Landscape (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
04/14/2021 $0.00 Complimentary CME Webinar!Wednesday, April 14, 2021 | 7:00 - 8:00 p.m. ESTPARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors.
Live Webinar 3: PARP Inhibitors: Best Practices in Advanced Prostate Cancer Care in the Community (2021)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
04/27/2021 $0.00 Complimentary CME Webinar!Tuesday, April 27, 2021 | 7:00 - 8:00 p.m. ESTPARP Inhibitors: From Research to Practice, an exciting new educational initiative, is a series of three interactive, case-based, live virtual courses, featuring a unique topic related to PARP Inhibitors.
Annual Review Course (2021) 06/04/2021 $1,435.00  For the ABU Qualifying (Part 1) Examination, residents need to possess basic urologic knowledge and an understanding of current American Urological Association practice guidelines. To fulfill this need, the AUA developed this course to disseminate current urologic knowledge and successfully prepare residents for the ABU examination.